cm 7116 has been researched along with ro 5-4864 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, T; Webb, GA | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Angerer, V; Auwärter, V; Bisel, P; Kempf, J; Moosmann, B; Westphal, F; Wilde, M | 1 |
3 other study(ies) available for cm 7116 and ro 5-4864
| Article | Year |
|---|---|
Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones.
Topics: Benzodiazepinones; Electrochemistry; Structure-Activity Relationship | 1977 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Topics: Benzodiazepines; Benzodiazepinones; Biotransformation; Chromatography, Liquid; Designer Drugs; Flurazepam; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Metabolic Detoxication, Phase I; Microsomes, Liver; Substance Abuse Detection; Tandem Mass Spectrometry | 2019 |